Concepedia
Statistics
Publications
12
Citations
476
H-Index
10
Active since
2003
Affiliations
Cancer Society of New Zealand(Current)
University of Auckland
Maurice Wilkins Centre
University of Bari Aldo Moro
Victoria University of Wellington
Maria R. Abbattista is an author at Cancer Society of New Zealand specializing in pharmacology, medicine, and cancer pharmacology.
Publications per year
2003–2023
The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
Christopher P. Guise, Maria R. Abbattista, Rachelle S. Singleton et al. · Cancer Research · 2010 · 187 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Diflavin Oxidoreductases Activate the Bioreductive Prodrug PR-104A under Hypoxia
Christopher P. Guise, Maria R. Abbattista, Smitha R. Tipparaju et al. · Molecular Pharmacology · 2011 · 65 citations
Medicine, Biochemistry, Pharmacology +17
The Role of Bystander Effects in the Antitumor Activity of the Hypoxia-Activated Prodrug PR-104
Annika Foehrenbacher, Kashyap Patel, Maria R. Abbattista et al. · Frontiers in Oncology · 2013 · 55 citations · Full text
Medicine, Oncology, Pharmacology +17
Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma
Maria R. Abbattista, Stephen M. F. Jamieson, Yongchuan Gu et al. · Cancer Biology & Therapy · 2015 · 37 citations · Full text
<i>E. coli</i> nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications
Alexandra M. Mowday, Janine N. Copp, Sophie P. Syddall et al. · Theranostics · 2020 · 25 citations · Full text
Medicine, Molecular Biology, Nuclear Medicine +17
1–5 of 12